• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对新冠肺炎的阿育吠陀个性化预防方案。

An Ayurvedic personalized prophylactic protocol in COVID-19.

作者信息

Nair Pratibha P, Nair Parvathy G, Pratap Shankar K M

机构信息

National Ayurveda Research Institute for Panchakarma, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Govt. of India, Cheruthuruthy, India.

National Ayurveda Research Institute for Panchakarma, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Govt. of India, Cheruthuruthy, India.

出版信息

J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100351. doi: 10.1016/j.jaim.2020.08.004. Epub 2020 Sep 8.

DOI:10.1016/j.jaim.2020.08.004
PMID:33334655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834287/
Abstract

The current COVID-19 pandemic brought about by the SARS-CoV-2, a novel β coronavirus is creating intense health havoc globally. Researchers suspect the situation to stay for long in the community, considering this virus's pathogenesis, high rate transmission and tendency to provoke uncontrolled immune response activation. Immune mechanisms are highly individualistic. We put forward a hypothetical model of prakruti (Ayurvedic body phenotyping character) based personalized prophylactic-therapeutic strategies aiming at a better immunomodulation and quicker resolution of host immune mechanisms. We propose this model in symptomatic, mild to moderate, COVID-19 diagnosed cases and in cases quarantined for high to low risk primary contact with a positive case. We also suggest a community level personalized Ayurvedic prophylactic-therapeutic strategy based on the DOTS model. Person-centered body purificatory measures (panchakarma procedures) like therapeutic purgation (virechana) and medicated enema (basti) are suggested in this hypothetical protocol with justification on evidence-based links between immune responses and prakruti along with specific jwara (fevers of varied origin as per Ayurvedic sciences) and COVID-19 symptomatology. The paper also appraises the importance of pitta dosha/ama dosha in the manifestation of inflammation driven destructive phase of immune responses along with its stage-wise intervention. This hypothetical model intends to open up discussions on significance of prakruti assessment as a predictive marker to screen people who are at risk of succumbing into deteriorating states if infected with COVID-19. It also intends to discuss the predictive personalized medicine measures based on prakruti in yielding individual host immune homeostasis which may positively reduce the chances of untoward events of an aggravated immune responsiveness and subsequent inflammation driven tissue destruction - the candidate causes for COVID-19 related casualties. Testing this model may give insight towards emphasizing personalized host immune coping mechanisms that may prove crucial in any infectious outbreaks in near future too.

摘要

由新型β冠状病毒严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的当前新冠疫情正在全球造成严重的健康破坏。考虑到这种病毒的发病机制、高传播率以及引发不受控制的免疫反应激活的倾向,研究人员怀疑这种情况将在社区中长期存在。免疫机制具有高度个体性。我们提出了一种基于体质(阿育吠陀身体表型特征)的假设模型,采用个性化的预防 - 治疗策略,旨在实现更好的免疫调节并更快地解决宿主免疫机制问题。我们在有症状的、轻度至中度的新冠确诊病例以及因与阳性病例有高风险至低风险的初次接触而被隔离的病例中提出此模型。我们还基于直接观察短程督导治疗(DOTS)模型提出了一种社区层面的个性化阿育吠陀预防 - 治疗策略。在这个假设方案中,建议采用以人为主的身体净化措施(五种疗法程序),如治疗性泻下(催吐疗法)和药浴灌肠(巴斯提疗法),并依据免疫反应与体质之间基于证据的联系以及特定的发热(根据阿育吠陀科学有多种起源的发热)和新冠症状学进行论证。本文还评估了火元素/毒素在炎症驱动的免疫反应破坏阶段表现中的重要性及其分阶段干预。这个假设模型旨在开启关于体质评估作为预测标志物的重要性的讨论,以筛选出如果感染新冠病毒就有陷入病情恶化状态风险的人群。它还打算讨论基于体质的预测性个性化医疗措施在实现个体宿主免疫稳态方面的作用,这可能会积极降低免疫反应加剧和随后炎症驱动的组织破坏这些不良事件的发生几率,而这些正是新冠相关伤亡的潜在原因。对这个模型进行测试可能有助于深入了解强调个性化宿主免疫应对机制的重要性,这在不久的将来应对任何传染病爆发时可能也至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/a3e26aca2b61/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/01b7650a141d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/c15e3a765cfc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/f78915b8be29/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/a3e26aca2b61/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/01b7650a141d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/c15e3a765cfc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/f78915b8be29/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ad/8718943/a3e26aca2b61/gr4.jpg

相似文献

1
An Ayurvedic personalized prophylactic protocol in COVID-19.一种针对新冠肺炎的阿育吠陀个性化预防方案。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100351. doi: 10.1016/j.jaim.2020.08.004. Epub 2020 Sep 8.
2
Personalized ayurvedic approach involving Sadyo Vamana in COVID-19 management: A case report.在新冠病毒疾病管理中采用涉及萨迪奥瓦马纳疗法的个性化阿育吠陀方法:一例报告。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100527. doi: 10.1016/j.jaim.2021.09.005. Epub 2021 Oct 1.
3
Chronic inflammation: Cross linking insights from Ayurvedic Sciences, a silver lining to systems biology and personalized medicine.慢性炎症:结合阿育吠陀科学的见解,为系统生物学和个性化医学带来一线希望。
J Ayurveda Integr Med. 2024 Jul-Aug;15(4):101016. doi: 10.1016/j.jaim.2024.101016. Epub 2024 Jul 16.
4
Pathophysiology of Covid-19 and host centric approaches in .新冠病毒病的病理生理学及以宿主为中心的方法
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100380. doi: 10.1016/j.jaim.2020.11.010. Epub 2020 Dec 2.
5
Effect of a Customized Panchakarma (bio-purificatory) Treatment Plan in a Case of Urethral Stricture with Cystitis: A Case Report.基于生物净化的个性化帕坦加利疗程对膀胱炎合并尿道狭窄病例的影响:病例报告。
Altern Ther Health Med. 2024 Nov;30(11):54-59.
6
in autoimmune pancreatitis: A single-case study.自身免疫性胰腺炎:一项单病例研究。
Ayu. 2019 Oct-Dec;40(4):242-246. doi: 10.4103/ayu.AYU_15_20. Epub 2021 Jan 14.
7
Ayurvedic Therapies to Target the Microbiome: Evidence and Possibilities.阿育吠陀疗法靶向微生物组:证据与可能性。
Altern Ther Health Med. 2024 Feb;30(2):76-83.
8
Ayurvedic constitution (prakruti) identifies risk factor of developing Parkinson's disease.阿育吠陀体质(prakruti)确定了帕金森病发病的危险因素。
J Altern Complement Med. 2013 Jul;19(7):644-9. doi: 10.1089/acm.2011.0809. Epub 2013 Mar 7.
9
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
10
Ayurvedic medicine. Core concept, therapeutic principles, and current relevance.阿育吠陀医学。核心概念、治疗原则及当前相关性。
Med Clin North Am. 2002 Jan;86(1):75-89, vii. doi: 10.1016/s0025-7125(03)00073-7.

引用本文的文献

1
Evaluation of Clove Phytochemicals as Potential Antiviral Drug Candidates Targeting SARS-CoV-2 Main Protease: Computational Docking, Molecular Dynamics Simulation, and Pharmacokinetic Profiling.丁香植物化学物质作为靶向SARS-CoV-2主要蛋白酶的潜在抗病毒药物候选物的评估:计算对接、分子动力学模拟和药代动力学分析。
Front Mol Biosci. 2022 Jun 28;9:918101. doi: 10.3389/fmolb.2022.918101. eCollection 2022.

本文引用的文献

1
Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses.新型人类冠状病毒(SARS-CoV-2):来自动物冠状病毒的启示。
Vet Microbiol. 2020 May;244:108693. doi: 10.1016/j.vetmic.2020.108693. Epub 2020 Apr 14.
2
COVID-19 pandemic: A pragmatic plan for ayurveda intervention.新冠疫情:阿育吠陀干预的务实计划
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100312. doi: 10.1016/j.jaim.2020.04.002. Epub 2020 Apr 23.
3
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs.COVID-19、免疫系统反应、过度炎症和重新利用抗风湿药物。
Turk J Med Sci. 2020 Apr 21;50(SI-1):620-632. doi: 10.3906/sag-2004-168.
4
Coronavirus disease 2019 (COVID-19): current status and future perspectives.新型冠状病毒病 2019(COVID-19):现状和未来展望。
Int J Antimicrob Agents. 2020 May;55(5):105951. doi: 10.1016/j.ijantimicag.2020.105951. Epub 2020 Mar 29.
5
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.中国湖北省 2019 年冠状病毒病(COVID-19)患者的眼部表现特征。
JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.
6
Understanding the association between the human gut, oral and skin microbiome and the Ayurvedic concept of prakriti.了解人类肠道、口腔和皮肤微生物组与阿育吠陀概念 prakriti 之间的关联。
J Biosci. 2019 Oct;44(5).
7
Can the vagus nerve serve as biomarker for vata dosha activity?迷走神经能否作为风型体质活动的生物标志物?
J Ayurveda Integr Med. 2019 Apr-Jun;10(2):146-151. doi: 10.1016/j.jaim.2019.04.003. Epub 2019 May 25.
8
The Inclusive Behavioral Immune System.包容性行为免疫系统。
Front Psychol. 2019 May 3;10:1004. doi: 10.3389/fpsyg.2019.01004. eCollection 2019.
9
Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer.肠道微生物组与免疫系统在传染病、免疫病理学和癌症中的相互作用。
Front Immunol. 2018 Aug 15;9:1830. doi: 10.3389/fimmu.2018.01830. eCollection 2018.
10
The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity.不断演变的红细胞:作为固有免疫调节剂的红血细胞。
J Immunol. 2018 Sep 1;201(5):1343-1351. doi: 10.4049/jimmunol.1800565.